A qualitative study exploring perspectives towards rational use of medicines in Pakistan’s Malaria Control Program (MCP) by Malik, Madeeha et al.
*Correspondence: M. Malik. Discipline of Social and Administrative Phar-
macy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 
- Minden - Penang, Malaysia. E-mail: mady_sweet1@yahoo.com
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 49, n. 2, apr./jun., 2013
A qualitative study exploring perspectives towards rational use of 
medicines in Pakistan’s Malaria Control Program (MCP)
Madeeha Malik1,*, Mohamed Azmi Hassali1, Asrul Akmal Shafie1, Azhar Hussain1,2
1Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia, 
2Hamdard Institute of Pharmaceutical Sciences, Hamdard University, Pakistan
Malaria is one of the most important global public health problems threatening the health of the population 
owing to prevailing socio-economic conditions and epidemiological reasons in Pakistan. This qualitative 
study has focused on the perspectives held towards the rational use of medicine intervention among 
malaria control program officials. Eight semi-structured interviews with all officials working for the 
malaria control program in Islamabad were conducted. The interviews, which were audio-taped and 
transcribed verbatim, were evaluated by thematic content analysis and by all authors. All respondents 
agreed on successful implementation of the malaria control program in Pakistan for controlling malaria 
by improving diagnostic and treatment facilities and promoting rational case management through 
training of prescribers. However, funding is still the major challenge faced by the program for its future 
implementation. 
Uniterms: Malaria. Malaria Control Program. Drug/rational use. Intervention. Pakistan.
A malária é um dos mais importantes problemas sanitários globais, que ameaça a saúde população devido 
às condições socioeconômicas e por razões epidemiológicas no Paquistão. Este estudo qualitativo focou-
se nas perspectivas no sentido do uso racional da intervenção médica entre os funcionários do programa 
de controle da malária. Oito entrevistas semiestruturas com todos os funcionários que trabalham no 
programa de controle da malária foram conduzidas em Islamabad. As entrevistas, que eram gravadas e 
transcritas, foram avaliadas por análise temática do conteúdo e por todos os autores. Todos os respondentes 
concordaram com o êxito da implementação do programa de controle da malária no Paquistão por meio 
do aprimoramento do diagnóstico e de facilidades do tratamento, promovendo a gestão racional por meio 
do treinamento dos prescritores. Entretanto, o financiamento é, ainda, o principal desafio enfrentado para 
a implementação futura do programa.
Unitermos: Malária. Programa de controle da malária. Fármaco/uso racional. Intervenção. Paquistão.
INTRODUCTION
Malaria is one of the most importantlargest global 
public health problems and imposes a major burden 
on health in developing countries. Half of the world’s 
population is at risk of malaria with an estimated 250 
million clinical cases and nearly one million deaths 
reported in 2006. This makes it the leading cause of 
morbidity and mortality globally, especially in pregnant 
women and children (Murtaza et al., 2009). Around five 
million confirmed cases of malaria are reported each 
year from countries outside Africa, of which almost 
three million are from India and Pakistan. However, it 
is generally assumed that the actual number of cases in 
the world is much greater. Many victims of malaria do 
not have access to diagnostic and treatment facilities; 
therefore, the prevalence of the disease is not always 
recorded and only a small number of cases are officially 
reported globally each year (WHO, 2005).
New approaches have been developed for malaria 
case management, for selective vector control and for 
epidemic detection. Effective medicines and preventive 
measures are available (UNICEF, 2000). Higher treatment 
coverage with well-equipped health services and safe 
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and effective antimalarial drugs need to be available 
and accessible to the whole population. However, these 
effective and relatively inexpensive interventions reach 
only a small proportion of the populations in need, 
mainly due to insufficient financial resources (Kouyate 
et al., 2007). To resolve this dilemma, malaria has been 
integrated into national health programs and partnerships 
have been increased both internationally and nationally by 
the Roll Back Malaria (RBM), an initiative by the World 
Health Organization (WHO), which has led to increased 
global awareness of malaria (Nigeria, 2010).
Over the years, malaria eradication or control has 
been the goal of many developing countries. Nearly 90 
countries have a national malaria control program (MCP) 
to combat malaria. The Global Fund is one of the biggest 
international donors and currently contributes two thirds 
of all international finance for malaria, supporting 175 
malaria-specific programs in 83 countries (WHO, 2009). 
It was created in 2002 to dramatically attract, manage and 
disburse resources to the areas of greatest need. It does 
not directly implement programs, but instead relies on a 
broad network of partners with national MCPs within the 
affected countries to strengthen their health systems by 
financing these programs and supplying local knowledge 
and technical assistance (Malaria Policy Center, 2010).
The national MCPs vary from country to country, 
and depend on the malaria statistics and current needs of 
the country. As malaria morbidity and mortality continue 
to increase in most countries, the international agencies 
and MCPs have strenghthened undividual programs 
by utilising available resources, developing quality 
control strategies, effective program decision making 
and continuous program evaluation for improving the 
efficiency and effectiveness of these programs (Bryce 
et al., 1994). An integrated MCP was developed and 
implemented in Ghana in 2006 and was successful in the 
control of malaria in this country. Ongoing surveillance, 
monitoring, research and partnership with the relevant 
authorities and with local communities were considered 
factors responsible for the success of the program 
(USAID, 2011). Another successful program (PAL+) for 
malaria control by the French ministry was launched in 
1999 and focused on developing methods of prevention 
and treatment of malaria and other communicable diseases 
for countries in Sub-Saharan Africa, Southeast Asia and 
Latin America (Agid, 2004). The national MCP of Zambia 
was also successful in reducing the rate of deaths due to 
malaria (Malaria Control Program, 2009). On the other 
hand, many MCPs have failed to accomplish what they 
initially planned. Problems evident in the success of these 
projects have involved logistic and financial constraints 
and poor project program management. An example of 
such a failure is the national MCP of Burkina Faso which 
was not successfully implemented due to lack of funds 
(Kouyate et al., 2007).
Pakistan is among 109 countries with endemic 
malaria with an estimated 1.5 million annual malaria 
episodes (Murtaza et al., 2009). It is a major health 
problem, threatening the health of the people due 
to prevailing socio-economic conditions and the 
epidemiological situation (Malik et al., 2011). A MCP was 
initiated in Pakistan in the 1950s and has passed through 
several evolutionary phases. In 1975, a malaria control 
strategy was adopted with provincial commitment to 
implementation and in 1998, Pakistan joined the global 
Roll Back Malaria (RBM) initiative (Kakar et al., 2010). 
The present study was designed to explore the role of the 
MCP, major outstanding challenges faced in promoting 
rational drug use, achievements, and the future prospective 
of the program for advancing resource mobilisation and 
collaborative partnerships.
METHODS
Design and setting
The study was approved by a panel of experts at 
the MCP, Ministry of Health, Government of Pakistan. 
Because little research has been undertaken in Pakistan to 
explore the perspectives held towards the rational use of 
medicine intervention among MCP officials, qualitative 
research was adopted to explore the issue. The study was 
conducted at the MCP in Islamabad, which is controlled 
by the Ministry of Health, Government of Pakistan. 
The program operates through its Federal Directorate, 
Provincial Health Departments, EDO Health Officers 
and Microscopists at tertiary, secondary and primary 
healthcare levels in the country. The program is mainly 
funded by the Government of Pakistan and also receives 
22 million Us Dollars of global funding, annually. The 
program has implemented interventions for the control 
of malaria in nineteen districts from different provinces 
of Pakistan by involving international non-governmental 
organisations (NGOs), for example Mercy Corps, and the 
National Rural Support Program (NRSP).
Participants
Eight interviews with all of the officials working 
at the MCP in Islamabad were conducted. The officials 
were recruited through personal contacts. The identified 
participants were contacted in person or by telephone to 
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arrange interview appointments. Written consent was 
obtained from all participants prior to the interview.
Study tool
A semi-structured interview guide was used as a study 
tool. The interview guide was developed after extensive 
literature review. A number of aspects to be addressed 
were already identified from the literature and this ensured 
that the key issues regarding the role of the MCP were 
covered with all respondents. While creating the questions, 
the focus was to keep the questions as open as possible to 
give interviewees a maximum opportunity to express their 
views. The first draft of the interview guide was discussed 
among the authors and was modified after a few rounds of 
discussion. The pre-testing of the guide was conducted with 
four MCP officials to check whether particular questions 
were useful in the retrieval of information. Specific probes 
were identified during the pilot interviews and the interview 
guide was subsequently modified.
Procedure and interview process
The interviews were conducted from April to May 
2011 at the offices of the respondents. The interviews 
mainly focused on the perceptions of MCP officials on 
current scenarios of rational drug use in cases of malaria, 
major challenges in promoting rational drug use in 
malaria, drug management, current achievements of the 
program and its future prospective. Probing questions were 
used where necessary and participants were given freedom 
to express their views at the end of the interview session. 
Each interview lasted approximately 20 to 30 minutes 
at a time convenient for the respondents. All interviews 
were conducted in the local language. Permission for 
recording was obtained and all interviews were recorded. 
Each interview was transcribed verbatim. Transcribed 
interviews were subjected to thematic content analysis, 
and the transcripts were analysed for relevant content to 
identify the emerging categories (Malik et al., 2011).
RESULTS
The interviews with officials focused on three major 
components, i.e. working and outreach of the program, 
strategies and major challenges faced for promoting 
rational drug use in malaria control, and achievements and 
the future prospective of the program. Thematic content 
analysis of these components yielded additional major 
themes and sub-themes. The demographics of the MCP 
officials are given in Table I.
THEMES
Theme 1: Outreach and major partners of the 
MCP
The MCP has mainly targeted 19 districts in different 
provinces, where they are working with the collaborative 
efforts of the Government of Pakistan and the Global Fund 
as stated by all the officials.
“The outreach of the program is in 19 districts in 
different provinces. Our major partners are the Global 
Fund and the Government of Pakistan. We are working in 
coordination with government officers to promote capacity 
building of the professionals”. (MCP.O 3)
“Basically we are targeting 19 districts of Pakistan 
in different provinces. Our major partners are the Global 
Fund and the Government of Pakistan. We have six sub-
recipients, basically international NGOs who are also 
working as our major partners in the implementation of 
the program”. (MCP.O 6)
TABLE I - Demographic characteristics of officials working in the MCP, Pakistan
Code Gender Qualification Experience Current designation
MCP.O 1 Male MBBS/MPH 4 years WHO coordinator
MCP.O 2 Female MBBS/MPH 2 years Monitoring and evaluation officer
MCP.O 3 Female MBBS/MPH 4 years Project officer
MCP.O 4 Male Masters in social sciences 1 year Monitoring and evaluation officer
MCP.O 5 Male MBBS 2 years Monitoring and evaluation officer
MCP.O 6 Male Masters in Pharmacy 4 years Procurement and supply manager
MCP.O 7 Male B-pharmacy/LLB/DPH 2 years Human resources and logistics manager
MCP.O 8 Male MBA Management  2 years Finance and accounts manager
MCP.O = malaria control program official
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Theme 2: Provision of facilities by the program
Diagnostic kits, free medicines, nets, trained staff 
and rational case management were seen as the major 
facilities provided by the officials.
“We provide diagnostic kits and nets for vulnerable 
groups like pregnant women and children under five. 
Beside this we provide training to the doctors and ensure 
availability of free of cost drugs at these facilities. We 
identify centres which are functional and have staff. Then 
we train the doctors at these centres according to WHO 
guidelines. We also ensure the training of a microscopist 
for proper diagnosis at these facilities so that we can get 
accurate data from these facilities. We have designed 
a proper information system, get data on a daily basis 
through emails from all these facilities and update the 
system regularly”. (MCP.O 3)
“According to a study of 2006, it  has been 
reported that there were about 1.6 million suspected 
cases of malaria in Pakistan out of which confirmed 
cases were only around 300,000, but according to the 
pharmaceutical sales figures of 2006 it has been seen 
that around seventy million doses of antimalarial drugs 
had been sold which was unjustified. Chloroquine 
and any antimalarial drugs can easily be purchased 
from the market for the treatment of malaria without 
confirmation. We don’t have enough microscopist centres 
and results were available after 24 hours. Therefore we 
improved the diagnostic facilities and functioning of 
microscopic centres. Previously, one microscopist centre 
was available for every 44,000 people but now we have 
attained a target of 43,000. We have also introduced 
rapid diagnostic kits through which malaria is confirmed 
in 20 minutes”. (MCP.O 4)
Theme 3: Major contributing factors in irrational 
drug use in treatment of malaria in Pakistan
In view of most of the officials’ inappropriate 
diagnoses, antimalarial resistance, lack of trained staff 
and inappropriate drug management are the major factors 
promoting irrational drug use in the treatment of malaria 
in Pakistan.
“Irrational prescribing is common and resistance 
is the major problem seen while treating malaria. 
Chloroquine and other antimalarial drugs are being 
prescribed so frequently to the patients without 
confirmation that they are usually ineffective when used 
by the patients who are actually suffering from malaria”. 
(MCP.O 2)
“Lack of diagnostic facilities, improper diagnosis 
and lack of trained microscopists are the major reasons 
for irrational practice in cases of malaria. Lack of training 
of doctors is another issue which needs to be addressed. 
Treatment should be given to confirmed cases of malaria 
only”. (MCP.O 4)
“I think the major factors contributing towards 
irrational drug use in the treatment of malaria are 
improper formularies, a flawed procurement process, 
quantification and forecasting of antimalarial drugs 
without any proper methodology, inappropriate storage 
conditions and distribution mechanisms, unethical 
prescribing practices, a large number of quacks and 
unavailability of antimalarial drugs especially in rural 
areas”. (MCP.O 6)
Theme 4: Role of the health care system in 
promoting rational drug use in the treatment of 
malaria in Pakistan
Most of the officials were of the view that the health 
care system has failed to play a positive role in promoting 
rational drug use in the treatment of malaria in Pakistan.
“I don’t think that the health care system is playing 
any significant role in the treatment of malaria. The 
government spending of the total expenditure on health 
care is so small that even the tertiary care hospitals 
don’t have sufficient funds, so how can one expect that 
the funds will be tripled down to the basic health units 
and dispensaries? Major antimalarial drugs stockouts 
are seen. The health care system should promote cost 
effective treatment as not everybody has the capacity to 
buy medicines”. (MCP.O 1)
“I have not heard of any promotion strategy and 
achievements regarding rational drug use in cases of 
malaria by the health care system in Pakistan. I have 
always come across irrational prescribing practices of 
antimalarial drugs”. (MCP.O 2)
“I don’t think the health care system has directly 
contributed any vital role in the promotion of rational drug 
use in the treatment of malaria”. (MCP.O 8)
Theme 5: Role of the MCP in promoting rational 
drug use in Pakistan
Appropriate diagnosis, treatment, implementation 
of standard malaria treatment guidelines and appropriate 
management of antimalarial drugs were seen as the key 
roles by most of the officials.
Appropriate diagnosis and treatment
“Our strategy is based on proper diagnosis 
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and treatment. There are defined procedures of case 
management on the basis of which health care providers 
are being trained and then treat accordingly. In this 
way, rational drug use is ensured such that only WHO 
recommended medicines are being used”. (MCP.O 5)
“Early diagnosis and then treatment of the positive 
cases is the focus of our strategy for promoting rational 
drug use in the treatment of malaria”. (MCP.O 7)
Development and training of standard treatment 
guidelines of malaria
“Training of standard treatment guidelines, known 
as “case management training”, is conducted. Desk 
guides and manuals are provided. One doctor at every 
facility is trained for three days and later they train their 
staff. There are certain places in Baluchistan and Sind 
where there are no doctors, so shorter training of one 
or two days is provided to the care providers at these 
facilities, who are usually female health workers or 
dispensers”. (MCP.O 1)
“A strategic plan of malaria has been made which 
is being revised after every five years. The strategic plan 
includes the intention that standard treatment guidelines 
for malaria will be implemented which will control 
rational drug use”. (MCP.O 4)
Appropriate drug management of antimalarials
“There are special guidelines of the Global 
Fund which indicate that all antimalarial drugs and 
all prequalified suppliers should be WHO certified. 
In the case of antimalarial drugs, the procurement 
is usually based on the morbidity method and the 
annual parasite index is calculated. 30% extra stock is 
procured compared to the total district load of malaria 
cases. Usage is reviewed quarterly through the malaria 
information system which indicates the number of drugs 
consumed in a particular month in a specific facility. 
Drugs are then transferred to the facility with a higher 
load. This system ensures drug availability and monitors 
drug stockouts at health facilities. Buffered stocks are 
kept at a regional level for emergency needs. That is how 
rational procurement of antimalarial drugs has been 
ensured”. (MCP.O 4)
“A procurement plan is made which focuses on 
estimation of antimalarial drugs on the basis of case 
loads and statistics. The availability of antimalarial drugs 
in the malaria peak season is ensured. Stockouts are 
regularly monitored and the inter-district distribution of 
antimalarial drugs is carried out on the basis of malaria 
load. In time, procurement is the strategy of our program 
to promote rational drug use”. (MCP.O 5)
Theme 6: Major challenges faced by MCP in 
promotion of rational drug use
Most of the officials consider funding constraints, 
irregular monitoring and patient compliance as the major 
challenges faced in promoting rational drug use in malaria.
“We can make sure that patient has taken the first 
dose of the antimalarial drug but cannot ensure adherence 
of the patient to the rest of the therapy, like dots in 
tuberculosis. Secondly, microscopy which is considered 
as gold standard in appropriate diagnosis can only be 
relied upon if the microscopist is supervised regularly. 
Although we train microscopists, it is difficult to monitor 
whether they are performing the tests appropriately or 
not”. (MCP.O 1)
“Due to vast distances between health facilities 
in Baluchistan, it is not possible for EDOs to frequently 
monitor these settings. Lack of funds is another major 
challenge faced by the program”. (MCP.O 5)
Theme 7: Effectiveness of strategy by MCP
In view of most of the officials’ identification and 
registration of more malaria cases, training of doctors, 
positive feedback from the public, continued funding from 
the donors and verification of dispensing of antimalarial 
drugs only to confirmed cases are seen as indicators which 
confirm the effectiveness of the strategy.
“This is, for the first time in the history that, after 
two years the MCP in Pakistan has been evaluated, and 
approved for funding of phase II by the Global Fund. 
Beside this, we received positive feedback from the public. 
As diagnostic facilities have been improved, more cases 
are being diagnosed and documented. The confirmation 
of dispensing of antimalarial drugs to confirmed malaria 
cases only shows that the strategy has been effective”. 
(MCP.O 5)
“I think by training of prescribers and the provision 
of artemisinin combination therapy only to confirmed 
malaria patients, we have been successful in achieving 
rational drug use in the targeted districts”. (MCP.O 3)
Theme 8: Major achievements of the program
Most of the officials consider training, rational drug 
use, a low number of cases of resistance and effective 
treatment of confirmed cases of malaria as the major 
achievements of the program.
“In the first year, 40,000 positive cases of malaria 
were effectively treated”. (MCP.O 2)
“Only confirmed cases of malaria are treated by 
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the trained staff. I think we have ensured rational drug 
use through training of doctors in standard treatment 
guidelines and we perceive this as the major achievement 
of the program”. (MCP.O 3)
 “I think promotion of combined artemisinin therapy 
has been effective, as no case of resistance has been 
reported and the sale of antimalarial drugs has been 
reduced according to pharmaceutical reports which is a 
major achievement of the program”.(MCP.O 4)
Theme 9: Monitoring of the program
A monitoring plan and a review of the sale of 
antimalarial drugs are seen as the best tools for monitoring 
of the program by the officials.
“The antimalarial drugs procured and distributed 
are the same throughout the region. Drug specification, 
source, quality and supplier are the same which is in itself 
a check”. (MCP.O 1)
“A monitoring plan has been designed and 
monitoring officers regularly supervise the status of 
rational drug use. The numbers of confirmed malaria 
cases are verified with the consumption of antimalarials 
which gives a clear idea about deviation from rational 
drug use. We will improve day by day”. (MCP.O 6)
Theme 10: Future prospective of the program
Public awareness, proper coordination with the 
health care system and extensive coverage of the program 
are seen as the future prospective by officials.
“Proper coordination between the public and 
private sectors in the next five years will be ensured. We 
have involved the private sector, due to which more cases 
are being diagnosed. In this way more coverage will 
focus on identification of more malaria positive cases”. 
(MCP.O 3)
“In the past, we were more concerned about getting 
things functional. However, in future we will focus more on 
quality assurance and public awareness through training 
which will definitely increase the capacity of the MCP at 
both central and provincial level in Pakistan”. (MCP.O 8)
DISCUSSION
Malaria is one of the largest public health challenges 
still faced by health managers in Pakistan. A MCP was 
established in Pakistan in 1961. The respondents revealed 
that the major partners of the program are the Global Fund 
and the Government of Pakistan who work together to 
promote capacity building of professionals involved in 
the treatment and control of malaria in this country. The 
MCP of Pakistan has successfully completed phase I of 
the malaria proposal and the Global Fund has approved 
donation for phase II. The activities mentioned in the 
work plan are being implemented through a public-private 
partnership model which includes the Government of 
Pakistan, international NGOs and the WHO. A similar 
collaborative model for successful implementation of the 
national MCP in Bangladesh has been reported (Malaria 
Control Program, 2010).
The officials of MCPs have stated that the number 
and functionality of diagnostic centres has been improved 
through the provision of rapid diagnostic kits and training 
of microscopists. Provisions of free of cost treatment to 
only confirmed malaria cases and an impregnated net for 
pregnant women and children under five have also been 
provided. Similar facilities have been provided by the 
national MCP in Uganda (2010).
Irrational use of drugs in the health care system 
remains a major challenge to be addressed. The problem 
of present irrational practices in the treatment of 
malaria in the health care system is contributing to the 
development of resistance, ineffective treatment and 
economic burden to both patients and society (Olliaro, 
2005). Irrational prescribing, resistance to antimalarial 
drugs and inappropriate diagnosis were highlighted 
by the respondents as the major factors contributing to 
irrational drug use in malaria. Resistance to the standard 
recommended antimalarial drugs is being witnessed, 
including artemether in Pakistan (Khatoon et al., 2009). 
High prevalence of in vivo resistance to chloroquine 
has been reported, although no high grade resistance 
to sulphadoxine-pyrimethamine by P. falciparum in 
southern Pakistan has been found (Ghanchi et al., 2011). 
Falciparum malaria accounts for 18% to 62% of all cases 
of malaria in different regions of Pakistan with resistance 
to one or more antimalarial drugs reaching up to 40% 
at present. Several studies conducted in Pakistan have 
reported a more prevalent resistance of falciparum malaria 
to chloroquine; the use of artimisinin derivatives is more 
effective but too costly for a developing country to be used 
on large scale (Shah et al., 1997, Rana, 2004 #257, Fox et 
al., 1985, Ejaz et al., 2007). Similar patterns of irrational 
drug use have been reported in Ghana and Cambodia 
(Chareonkul et al., 2002; Abuakua et al., 2005).
Rational use of drugs at health centres remains 
a problem in Pakistan. Despite improvements through 
different interventions in pharmaceutical selection, 
procurement, distribution, and financing, the problem of 
rational drug use still persists. It is often observed that 
prescribing and dispensing practices are not up to the mark 
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in public and private sector health facilities of developing 
countries including Pakistan (Nizamani et al., 2006). Most 
medical practitioners in developing countries including 
Pakistan are inclined to practice their own protocols to 
treat malaria rather than adhering to standard regimens 
which in turn promotes irrational drug use and leads to 
the emergence of higher rates of resistance to antimalarial 
drugs (WHO, 2002). Most of the respondents considered 
the design and implementation of national treatment 
guidelines for malaria through training of the prescribers 
as the best tool to address these issues contributing to 
irrational drug use in malaria.
One way to promote rational use is to ensure that 
all essential antimalarial drugs are available on a regular 
basis (Mannan et al., 2009). The MCP officials claimed 
that the availability of antimalarial drugs at health facilities 
has been ensured through the malaria information system 
which indicates the number of drugs consumed in a 
particular month at a specific health facility.
The respondents were of the view that the MCP has 
been able to control malaria to a considerable extent in the 
targeted districts and no case of drug resistance has been 
reported, which is seen as the major achievement of the 
program. These improvements are due to better diagnostic 
and treatment facilities. A similar strategy of improved 
diagnostic facilities and treatment adopted by the national 
MCP has been successful in reducing the number of 
malaria cases in Iran (Raeisi et al., 2009).
CONCLUSION
The MCP in Pakistan has targeted high endemic 
areas which focus on the 19 districts of the country. All 
respondents agreed on successful implementation of the 
MCP in Pakistan in controlling malaria by improving 
diagnostic and treatment facilities and promotion of 
rational case management through training of prescribers. 
Free of cost treatment only to confirmed malaria cases and 
impregnated nets for pregnant women and children under 
five have also been provided. Although the MCP of Pakistan 
has been successful in achieving its target and has been 
eligible for funding of the second phase, the funds from 
international donors are still under competitive pressure. 
There is no assurance that international donors are a 
sustainable source of finance. The failure of national MCPs 
in several developing countries due to lack of funds for their 
implementation has been a common reason. In spite of the 
challenges ahead, the Government of Pakistan, private 
sector stakeholders and development partners have to unite 
their efforts and work together to expand the national MCP 
and achieve the national millennium development goals. 
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